Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- наукова стаття, опублікована в січні 1995 (uk)
- articolo scientifico (pubblicato il 1995) (it)
- artículu científicu espublizáu en xineru de 1995 (ast)
- artikull shkencor i botuar më 01 janar 1995 (sq)
- scientific article published on 01 January 1995 (en)
|
publication date
| |
publication date
| |
cites work
| |
cites work
| |
author name string
| |
author name string
| |
rdfs:label
| - The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (en)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (nl)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (sq)
|
skos:prefLabel
| - The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (en)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (nl)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (sq)
|
name
| - The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (en)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (nl)
- The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (sq)
|
title
| |
title
| - The selective 5-HT2A receptor antagonist MDL 100,907 counteracts the psychomotor stimulation ensuing manipulations with monoaminergic, glutamatergic or muscarinic neurotransmission in the mouse--implications for psychosis (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
is about
of | |
is cites work
of | - The alpha2 adrenergic receptor antagonist idazoxan, but not the serotonin-2A receptor antagonist M100907, partially attenuated reward deficits associated with nicotine, but not amphetamine, withdrawal in rats
- NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia
- Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacy
- 5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB
- Network interactions in schizophrenia - therapeutic implications
- 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion
- Modulation of phencyclidine-induced changes in locomotor activity and patterns in rats by serotonin
- Neurotransmitter interactions in schizophrenia--therapeutic implications
- On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder
- Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications
- MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride
- The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice.
- Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5-HT2Asites for PCP-induced locomotion in the rat
- Emerging roles for novel antipsychotic medications in the treatment of schizophrenia
- Modulation of ligand-gated ion channels by antidepressants and antipsychotics
- Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies
- Nefazodone attenuates the behavioral and neurochemical effects of ethanol.
- Ketanserin reverses dizocilpine-suppression of morphine dependence but not tolerance in mice
- The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)
- Preclinical models of antipsychotic drug action
- Comparison of neurotensin responses to MDL 100,907, a selective 5HT2A antagonist, with clozapine and haloperidol.
- Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine
- MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems
- Why do schizophrenic patients hallucinate?
- Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex
- Synchronous dynamics for cognitive coordination: But how?
- Cognitive coordination and its neurobiological bases: A new continent to explore
- Phenomenology, context, and self-experience in schizophrenia
|
is cites work
of | |